Comprehensive multiple molecular profile of epithelial mesenchymal transition in intrahepatic cholangiocarcinoma patients.

The aim of this study is to investigate the expression profile of multiple epithelial mesenchymal transition (EMT)-related molecules in intrahepatic cholangiocarcinoma (ICC) and the related prognostic significance.Immunohistochemistry was performed to determine the expression of E-cadherin, Vimentin...

Full description

Bibliographic Details
Main Authors:	Xiao-Yong Huang, Chi Zhang, Jia-Bin Cai, Guo-Ming Shi, Ai-Wu Ke, Zhao-Ru Dong, Peng-Fei Zhang, Jia Fan, Bao-Gang Peng, Jian Zhou
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2014-01-01
Series:	PLoS ONE
Online Access:	http://europepmc.org/articles/PMC4016113?pdf=render

Similar Items

miR-204 Inhibits Epithelial to Mesenchymal Transition by Targeting Slug in Intrahepatic Cholangiocarcinoma Cells
by: Ying-he Qiu, et al.
Published: (2013-11-01)

SQSTM1/p62 in intrahepatic cholangiocarcinoma promotes tumor progression via epithelial–mesenchymal transition and mitochondrial function maintenance
by: Jiafeng Chen, et al.
Published: (2023-01-01)

AZGP1 activation by lenvatinib suppresses intrahepatic cholangiocarcinoma epithelial-mesenchymal transition through the TGF-β1/Smad3 pathway
by: Liming Deng, et al.
Published: (2023-09-01)

FXR Acts as a Metastasis Suppressor in Intrahepatic Cholangiocarcinoma by Inhibiting IL-6-Induced Epithelial-Mesenchymal Transition
by: Bei Lv, et al.
Published: (2018-07-01)

Prognostic significance of Capn4 overexpression in intrahepatic cholangiocarcinoma.
by: Chi Zhang, et al.
Published: (2013-01-01)

Metformin exerts anti-cancerogenic effects and reverses epithelial-to-mesenchymal transition trait in primary human intrahepatic cholangiocarcinoma cells
by: Sabina Di Matteo, et al.
Published: (2021-01-01)

Epithelial–Mesenchymal Transition in Liver Fluke-Induced Cholangiocarcinoma
by: Kanlayanee Sawanyawisuth, et al.
Published: (2021-02-01)

Intrahepatic cholangiocarcinoma
by: A. B. Luk’yanchenko, et al.
Published: (2016-02-01)

SARCOMATOID CHANGE IN INTRAHEPATIC CHOLANGIOCARCINOMA
by: Wewer Albrechtsen, et al.
Published: (2013-01-01)

Sarcomatoid change in intrahepatic cholangiocarcinoma
by: Albrechtsen Wewer Nicolai, et al.
Published: (2013-03-01)

Management of Intrahepatic Cholangiocarcinoma
by: Sudha Kodali, et al.
Published: (2021-05-01)

Asbestos and Intrahepatic Cholangiocarcinoma
by: Giovanni Brandi, et al.
Published: (2020-02-01)

Patient-Derived Xenograft Models for Intrahepatic Cholangiocarcinoma and Their Application in Guiding Personalized Medicine
by: Yang Gao, et al.
Published: (2021-07-01)

Intrahepatic Cholangiocarcinoma Associated with Intrahepatic Duct Stones
by: Hoon Hur, et al.
Published: (2009-01-01)

Comprehensive molecular profiling of intrahepatic cholangiocarcinoma in the Chinese population and therapeutic experience
by: Longrong Wang, et al.
Published: (2020-07-01)

The focus clinical research in intrahepatic cholangiocarcinoma
by: Yinghui Song, et al.
Published: (2022-07-01)

Advance in Therapeutic Targets of Intrahepatic Cholangiocarcinoma
by: LIN Jian, et al.
Published: (2021-03-01)

Oncogenic activation revealed by FGFR2 genetic alterations in intrahepatic cholangiocarcinomas
by: Xiaohong Pu, et al.
Published: (2023-11-01)

Elevated TRIM44 promotes intrahepatic cholangiocarcinoma progression by inducing cell EMT via MAPK signaling
by: Rui Peng, et al.
Published: (2018-03-01)

The clinical value of regional lymphadenectomy for intrahepatic cholangiocarcinoma
by: Facai Yang, et al.
Published: (2022-01-01)

Intratumor microbiome features reveal antitumor potentials of intrahepatic cholangiocarcinoma
by: Xiaoqiang Chai, et al.
Published: (2023-12-01)

EYA4 gene functions as a prognostic marker and inhibits the growth of intrahepatic cholangiocarcinoma
by: Xiao-Yi Hao, et al.
Published: (2016-07-01)

Diagnosis of intrahepatic cholangiocarcinoma with CEUS
by: Velardi Giancarlo Gismondo, et al.
Published: (2024-02-01)

Molecular Profile of Intrahepatic Cholangiocarcinoma
by: Wellington Andraus, et al.
Published: (2023-12-01)

Surgical Aspects of Intrahepatic Cholangiocarcinoma
by: Amram Kupietzky, et al.
Published: (2022-12-01)

Locoregional Therapy for Intrahepatic Cholangiocarcinoma
by: Mackenzie Owen, et al.
Published: (2023-04-01)

Intrahepatic Cholangiocarcinoma with Sarcomatous Changes
by: Yoshiyuki Inoue, et al.
Published: (2012-01-01)

Recurrent Intrahepatic Cholangiocarcinoma – Review
by: Yuki Bekki, et al.
Published: (2021-10-01)

Preoperative subcategorization based on magnetic resonance imaging in intrahepatic cholangiocarcinoma
by: Yuyao Xiao, et al.
Published: (2023-02-01)

Correction to: The focus clinical research in intrahepatic cholangiocarcinoma
by: Yinghui Song, et al.
Published: (2022-09-01)

TGF-β1 expression is associated with invasion and metastasis of intrahepatic cholangiocarcinoma
by: Yijie Chen, et al.
Published: (2015-01-01)

Intrahepatic Cholangiocarcinoma: State of the Art of FGFR Inhibitors
by: Tianyu Wu MD, et al.
Published: (2021-02-01)

A novel murine model of combined hepatocellular carcinoma and intrahepatic cholangiocarcinoma
by: Ru-Chen Xu, et al.
Published: (2022-12-01)

Anti-PD-1 Immunotherapy and Radiotherapy for Stage IV Intrahepatic Cholangiocarcinoma: A Case Report
by: Ze-Long Liu, et al.
Published: (2020-08-01)

Alterations of gut mycobiota profiles in intrahepatic cholangiocarcinoma
by: Lilong Zhang, et al.
Published: (2023-01-01)

The impact of cirrhosis on the prognosis of intrahepatic cholangiocarcinoma after surgery
by: Yanhong Fei, et al.
Published: (2023-03-01)

Multimodule characterization of immune subgroups in intrahepatic cholangiocarcinoma reveals distinct therapeutic vulnerabilities
by: Xiaoming Zhang, et al.
Published: (2022-07-01)

Novel discovery of PDPN-positive CAFs contributing to tumor-associated lymphangiogenesis through mesenchymal to lymphatic endothelial transition in intrahepatic cholangiocarcinoma
by: Meng Sha, et al.
Published: (2023-11-01)

Hepatic Arterial Infusion Chemotherapy for Unresectable Intrahepatic Cholangiocarcinoma, a Comprehensive Review
by: Marco Massani, et al.
Published: (2021-06-01)

Integrative analyses identify CD73 as a prognostic biomarker and immunotherapeutic target in intrahepatic cholangiocarcinoma
by: Bao-Ye Sun, et al.
Published: (2023-03-01)